Yokoe T, Iino Y, Maemura M, Takei H, Horiguchi J, Matsumoto H, Morishita Y, Koibuchi Y
Department of Emergency and Critical Care Medicine, Gunma University School of Medicine, Japan.
Anticancer Res. 1998 Nov-Dec;18(6B):4709-11.
Screening mammography (MMG) for women aged 50 years and older has been widely accepted all over the world. However, the efficacy of screening mammography for women aged under 50 years has not been established. We compared mammographic findings of the patients under age 50 (the younger group) and those of patients 50 and older (the older group). From 1992 to 1997, 107 patients with early breast cancer (non-invasive and Stage I) were treated in our hospital. There was no difference between the groups in background. Of 53 patients in the younger group, 40 (75.5%) were diagnosed as having cancer using mammography, while 44 of 54 (81.5%) of the older group were diagnosed as having cancer. A total of 46 (86.8%) patients in the younger group were diagnosed using MMG and physical examination (PE), and 50 (92.6%) in the older group were diagnosed as cancer using MMG and PE. There was no difference in the successful diagnosis rate using mammography in the two groups. Breast cancer screening using MMG may also be useful for women aged under 50.
50岁及以上女性的乳腺钼靶筛查(MMG)已在全球广泛接受。然而,50岁以下女性乳腺钼靶筛查的有效性尚未确立。我们比较了50岁以下患者(较年轻组)和50岁及以上患者(较年长组)的钼靶检查结果。1992年至1997年,我院治疗了107例早期乳腺癌(非浸润性和I期)患者。两组在背景方面无差异。较年轻组的53例患者中,40例(75.5%)通过钼靶检查诊断为癌症,而较年长组的54例中有44例(81.5%)诊断为癌症。较年轻组共有46例(86.8%)患者通过乳腺钼靶检查和体格检查(PE)确诊,较年长组有50例(92.6%)通过乳腺钼靶检查和PE诊断为癌症。两组使用钼靶检查的成功诊断率无差异。对50岁以下女性进行乳腺钼靶筛查也可能有用。